0000920465-21-000005.txt : 20210202 0000920465-21-000005.hdr.sgml : 20210202 20210202172001 ACCESSION NUMBER: 0000920465-21-000005 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210115 FILED AS OF DATE: 20210202 DATE AS OF CHANGE: 20210202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hearne Michael S CENTRAL INDEX KEY: 0001759910 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36282 FILM NUMBER: 21582725 MAIL ADDRESS: STREET 1: 4747 EXECUTIVE DRIVE STREET 2: SUITE 210 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4747 EXECUTIVE DRIVE, SUITE 240 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-207-4264 MAIL ADDRESS: STREET 1: 4747 EXECUTIVE DRIVE, SUITE 240 CITY: SAN DIEGO STATE: CA ZIP: 92121 4/A 1 wf-form4a_161230438355385.xml FORM 4/A X0306 4/A 2021-01-15 2021-01-20 0 0000920465 LA JOLLA PHARMACEUTICAL CO LJPC 0001759910 Hearne Michael S C/O LA JOLLA PHARMACEUTICAL COMPANY 4747 EXECUTIVE DRIVE, SUITE 240 SAN DIEGO CA 92121 0 1 0 0 Chief Financial Officer Common Stock 2021-01-15 4 A 0 136 4.5475 A 2571 D These shares were acquired on 1/15/2021 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). This is adjusted to 2,571 from 1,094 in Form 4 filed on 1/20/21 /s/ Michael Hearne 2021-02-02